Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions that preferentially potentiate subtypes of GABAA receptors and methods of use thereof

Compositions that preferentially potentiate subtypes of GABAA receptors and methods of use thereof

US Patent 11571432 · Granted Feb 7, 2023

Estimated economic value: $2,501,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating rheumatic diseases using trimetazidine-based compounds2025
Compositions and methods for increasing efficiency of cardiac metabolism2025
Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl] piperazin-1-yl]eth2024
Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyrid2024
Compositions and methods for increasing efficiency of cardiac metabolism2023
Inhalable imatinib formulations, manufacture, and uses thereof2023
Methods of synthesizing 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethy2023
Crystal forms of 2-[4-[(2,3,4- trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyri2023
N-acylethanolamide derivatives and uses thereof2023
Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyrid2022
Compositions and methods for increasing efficiency of cardiac metabolism2022
Inhalable imatinib formulations, manufacture, and uses thereof2022